199 related articles for article (PubMed ID: 26732518)
21. Characterization of bone mineral-resembling biomaterials for optimizing human osteoclast differentiation and resorption.
Nakamura M; Hentunen T; Salonen J; Nagai A; Yamashita K
J Biomed Mater Res A; 2013 Nov; 101(11):3141-51. PubMed ID: 23554241
[TBL] [Abstract][Full Text] [Related]
22. Phase composition, mechanical performance and in vitro biocompatibility of hydraulic setting calcium magnesium phosphate cement.
Klammert U; Reuther T; Blank M; Reske I; Barralet JE; Grover LM; Kübler AC; Gbureck U
Acta Biomater; 2010 Apr; 6(4):1529-35. PubMed ID: 19837194
[TBL] [Abstract][Full Text] [Related]
23. In vivo evaluation of bone marrow stromal-derived osteoblasts-porous calcium phosphate ceramic composites as bone graft substitute for lumbar intervertebral spinal fusion.
Kai T; Shao-qing G; Geng-ting D
Spine (Phila Pa 1976); 2003 Aug; 28(15):1653-8. PubMed ID: 12897487
[TBL] [Abstract][Full Text] [Related]
24. Gallium enhances reconstructive properties of a calcium phosphate bone biomaterial.
Strazic Geljic I; Melis N; Boukhechba F; Schaub S; Mellier C; Janvier P; Laugier JP; Bouler JM; Verron E; Scimeca JC
J Tissue Eng Regen Med; 2018 Feb; 12(2):e854-e866. PubMed ID: 28079305
[TBL] [Abstract][Full Text] [Related]
25. Behavior of macrophage and osteoblast cell lines in contact with the β-TCP biomaterial (beta-tricalcium phosphate).
Arbez B; Libouban H
Morphologie; 2017 Sep; 101(334):154-163. PubMed ID: 28506709
[TBL] [Abstract][Full Text] [Related]
26. Hemocyanin Modification of Chitosan Scaffolds with Calcium Phosphate Phases Increase the Osteoblast/Osteoclast Activity Ratio-A Co-Culture Study.
Kruppke B; Heinemann C; Farack J; Weil S; Aflalo ED; Sagi A; Hanke T
Molecules; 2020 Oct; 25(19):. PubMed ID: 33036488
[TBL] [Abstract][Full Text] [Related]
27. Biocompatibility evaluation of HDPE-UHMWPE reinforced β-TCP nanocomposites using highly purified human osteoblast cells.
Shokrgozar MA; Farokhi M; Rajaei F; Bagheri MH; Azari Sh; Ghasemi I; Mottaghitalab F; Azadmanesh K; Radfar J
J Biomed Mater Res A; 2010 Dec; 95(4):1074-83. PubMed ID: 20878932
[TBL] [Abstract][Full Text] [Related]
28. In vitro degradation and cell response of calcium carbonate composite ceramic in comparison with other synthetic bone substitute materials.
He F; Zhang J; Yang F; Zhu J; Tian X; Chen X
Mater Sci Eng C Mater Biol Appl; 2015 May; 50():257-65. PubMed ID: 25746269
[TBL] [Abstract][Full Text] [Related]
29. Hydrolysis of monetite/chitosan composites in α-MEM and SBF solutions.
Touny AH; Dawkins H; Zhou H; Bhaduri SB
J Mater Sci Mater Med; 2011 May; 22(5):1101-9. PubMed ID: 21479638
[TBL] [Abstract][Full Text] [Related]
30. PEGylated poly(glycerol sebacate)-modified calcium phosphate scaffolds with desirable mechanical behavior and enhanced osteogenic capacity.
Ma Y; Zhang W; Wang Z; Wang Z; Xie Q; Niu H; Guo H; Yuan Y; Liu C
Acta Biomater; 2016 Oct; 44():110-24. PubMed ID: 27544808
[TBL] [Abstract][Full Text] [Related]
31. Comparison of in vitro biocompatibility of NanoBone(®) and BioOss(®) for human osteoblasts.
Liu Q; Douglas T; Zamponi C; Becker ST; Sherry E; Sivananthan S; Warnke F; Wiltfang J; Warnke PH
Clin Oral Implants Res; 2011 Nov; 22(11):1259-64. PubMed ID: 21985282
[TBL] [Abstract][Full Text] [Related]
32. Effect of Si and Fe doping on calcium phosphate glass fibre reinforced polycaprolactone bone analogous composites.
Mohammadi MS; Ahmed I; Muja N; Almeida S; Rudd CD; Bureau MN; Nazhat SN
Acta Biomater; 2012 Apr; 8(4):1616-26. PubMed ID: 22248526
[TBL] [Abstract][Full Text] [Related]
33. Development of an osteoblast/osteoclast co-culture derived by human bone marrow stromal cells and human monocytes for biomaterials testing.
Heinemann C; Heinemann S; Worch H; Hanke T
Eur Cell Mater; 2011 Jan; 21():80-93. PubMed ID: 21267944
[TBL] [Abstract][Full Text] [Related]
34. Mechanical and biocompatible influences of chitosan fiber and gelatin on calcium phosphate cement.
Pan Z; Jiang P; Fan Q; Ma B; Cai H
J Biomed Mater Res B Appl Biomater; 2007 Jul; 82(1):246-52. PubMed ID: 17183561
[TBL] [Abstract][Full Text] [Related]
35. Novel soybean/gelatine-based bioactive and injectable hydroxyapatite foam: material properties and cell response.
Perut F; Montufar EB; Ciapetti G; Santin M; Salvage J; Traykova T; Planell JA; Ginebra MP; Baldini N
Acta Biomater; 2011 Apr; 7(4):1780-7. PubMed ID: 21163370
[TBL] [Abstract][Full Text] [Related]
36. [A novel tissue-engineered bone constructed by using human adipose-derived stem cells and biomimetic calcium phosphate scaffold coprecipitated with bone morphogenetic protein-2].
Jiang WR; Zhang X; Liu YS; Wu G; Ge YJ; Zhou YS
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Feb; 49(1):6-15. PubMed ID: 28202997
[TBL] [Abstract][Full Text] [Related]
37. Elucidating the individual effects of calcium and phosphate ions on hMSCs by using composite materials.
Danoux CB; Bassett DC; Othman Z; Rodrigues AI; Reis RL; Barralet JE; van Blitterswijk CA; Habibovic P
Acta Biomater; 2015 Apr; 17():1-15. PubMed ID: 25676583
[TBL] [Abstract][Full Text] [Related]
38. Effect of calcium phosphate phases affecting the crosstalk between osteoblasts and osteoclasts in vitro.
Shiwaku Y; Tsuchiya K; Xiao L; Suzuki O
J Biomed Mater Res A; 2019 May; 107(5):1001-1013. PubMed ID: 30684383
[TBL] [Abstract][Full Text] [Related]
39. A biomimetic gelatin-calcium phosphate bone cement.
Bigi A; Torricelli P; Fini M; Bracci B; Panzavolta S; Sturba L; Giardino R
Int J Artif Organs; 2004 Aug; 27(8):664-73. PubMed ID: 15478537
[TBL] [Abstract][Full Text] [Related]
40. Osteoclast differentiation from human blood precursors on biomimetic calcium-phosphate substrates.
Ciapetti G; Di Pompo G; Avnet S; Martini D; Diez-Escudero A; Montufar EB; Ginebra MP; Baldini N
Acta Biomater; 2017 Mar; 50():102-113. PubMed ID: 27940198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
